Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $1.85 -0.15 (-7.50%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.84 -0.01 (-0.27%) As of 07/11/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance The Inhibikase Therapeutics (IKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.15%, with a year-to-date return of -43.08%. In the past month, the stock has decreased 0.54%, reflecting recent market activity. As of the latest close, Inhibikase Therapeutics traded at $1.85 with a market cap of $137.53 million and volume of 151,265 shares. Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.96%1 Month Performance-0.54%3 Month Performance-10.63%Year-To-Date Performance-43.08%1 Year Performance+27.15% IKT Stock Chart for Sunday, July, 13, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$2.00$1.85-7.50%$1.97$1.81151,265 shs$137.53 million07/10/2025$2.02$2.00-0.99%$2.07$1.9975,867 shs$148.68 million07/09/2025$2.01$2.02+0.50%$2.09$1.98220,937 shs$150.17 million07/08/2025$1.93$2.01+4.15%$2.04$1.91156,955 shs$149.43 million07/07/2025$1.89$1.93+2.12%$1.97$1.85162,288 shs$143.48 million07/04/2025$1.89$1.89$1.90$1.8081,965 shs$140.51 million07/03/2025$1.85$1.89+2.16%$1.90$1.8081,965 shs$140.51 million07/02/2025$1.95$1.85-5.13%$1.97$1.83137,915 shs$137.53 million07/01/2025$1.95$1.95$1.97$1.82197,366 shs$144.97 million06/30/2025$1.62$1.95+20.37%$2.04$1.58440,917 shs$144.97 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$1.65$1.62-1.82%$1.67$1.567.06 million shs$120.43 million06/26/2025$1.67$1.65-1.20%$1.69$1.65177,400 shs$122.66 million06/25/2025$1.66$1.67+0.60%$1.71$1.62199,270 shs$124.15 million06/24/2025$1.66$1.66$1.78$1.65169,775 shs$123.41 million06/23/2025$1.66$1.66$1.69$1.56331,974 shs$123.41 million06/20/2025$1.70$1.66-2.35%$1.86$1.66278,054 shs$123.41 million06/19/2025$1.70$1.70$1.78$1.70188,985 shs$126.38 million06/18/2025$1.74$1.70-2.30%$1.78$1.70188,985 shs$126.38 million06/17/2025$1.94$1.74-10.31%$1.95$1.74226,848 shs$129.36 million06/16/2025$1.86$1.94+4.30%$1.97$1.85152,495 shs$144.22 million06/13/2025$1.91$1.86-2.62%$1.98$1.8592,001 shs$138.28 million06/12/2025$1.96$1.91-2.55%$2.03$1.9058,585 shs$141.99 million Related Companies AMLX Stock Price Chart TBPH Stock Price Chart ATAI Stock Price Chart KROS Stock Price Chart TLRY Stock Price Chart MNMD Stock Price Chart ORGO Stock Price Chart ZVRA Stock Price Chart TYRA Stock Price Chart TSHA Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IKT Stock Alerts